Neuroprogression in Psychiatry and Neurology: Advances in Research and Treatment

Edited by A. Halaris and B.E. Leonard, this volume brings together international experts to critically review the latest advances in neuroprogression research. The book delves into the relevance of these findings to psychiatric and neurological disorders, shedding light on potential etiopathological mechanisms of neuroprogression.

The Role of the Immune System in Stress and Stress-Related Disorders

The book places special emphasis on the role of the immune system in stress and stress-related disorders, as well as brain-immune interactions. It provides in-depth insights into the epigenetic consequences of adverse experiences in early childhood, which may prelude major psychiatric disorders.

Pharmacologic Interventions and Personalized Treatment Programs

Recent research has shown that pharmacologic interventions have the potential to arrest neuroprogression in psychiatric and neurological disorders. Advances in testing and imaging will lead to timely diagnosis and earlier treatment. Identification of neurological mechanisms alongside (epi-)genetic vulnerability markers will create truly personalized treatment programs.

A Valuable Resource for Researchers and Clinicians

This book is a valuable resource for everyone who wishes to gain insight into the essential features of the neuroprogressive course of major psychiatric and neurological disorders. In particular, psychiatrists, neuroscientists, and neurologists, as well as immunologists, pharmacologists, and molecular biologists, will find very informative chapters of direct relevance to their field.

Published by S. Karger, this book is part of the Modern Trends in Pharmacopsychiatry series, Vol. 31. It contains 182 pages and was published on August 2, 2017. The language of the book is English, and the ISBN-10 is 331806050X, with an ISBN-13 of 978-3318060508. The product dimensions are 7.7 x 0.7 x 10.3 inches.